Write a Review
You are here: Home > LAB LOCATOR SERVICE
A D.O.T. drug screen is a screen that tests a specimen for five NIDA drugs. According to DOT regulations, all DOT drug screens must be reviewed by an MRO. Nationwide drug testing centers available at Quest and Labcorp. A Non-DOT drug test is a drug screen not federally regulated by the department of transportation. REI recommends all non-negative presumptive positive results, whether DOT or NON be GC/MS confirmed by an HHS approved laboratory. Monday November 13, 2017, the Department of Transportation (DOT) published a final rule in the Federal Register. The final rule, among other items, added four semi-synthetic opioids (i.e., hydrocodone, oxycodone, hydromorphone, oxymorphone) to our drug testing panel. It also added methylenedioxyamphetamine (MDA) as an initial test analyte and removed the testing for methylenedioxyethylamphetaime (MDEA). The final rule became effective January 1st, 2018.

Online appointment scheduling is available for all LabCorp specimen collection sites. You can even schedule same-day appointments. (In those cases, appointments must be made two hours prior to time of arrival.)

Appointments are not required. Please be aware that not all services are available at all sites.

Simply click on Lab-Corp or Quest below and provide us with the zip code (s) of your job location. A company representative will locate the closest collection site to that zip code with the best possible price and medical service to suit your needs. The specimen (s) will be collected and shipped overnight to one of our SAMHSA Certified Laboratories. Negatives are reported within 24 hours of being shipped. Positives are confirmed by Gas Chromatography/ Mass Spectrometry (GC/MS). The positive result will be reviewed by one of our Certified Medical Review Officers (MRO) and reported usually within 24-72 hours.

labcorp collection sites
quest collection locator service
Utilize the Labcorp Patient Service Center Locator for Drug Screen Collection to locate the nearest Labcorp collection site – you will want to select “Occupational Urine Drug Screen Collections” as the type of service you desire.
Utilize the Quest Patient Service Center Locator for Drug Screen Collection to locate the nearest Quest collection site – you will want to Select “Employer and wellness services” as the reason for testing.
General Instructions
You must have a custody and control form (CCF) in your possession to receive drug testing services at a Labcorp or Quest facility.
Please note that hours vary for different services offered at a Patient Service Center. Be sure to contact the collection site BEFORE your visit to determine when those services are available
The Quest Diagnostic Patient Service Centers, 'Find a Location' locator site also lists non Quest PSC's. Be advised there may be an additional charge to use these 'Preferred' third party locations.

Random Selections

It is the preferred of many companies not to perform this duty for legal concerns. A TPA (third party agency) will perform this administrative task for you and randomly select the percent of employees you wish to test. This will eliminate any questions of unfairness for this process. Choose one with randomize software technology.
MRO & Lab Services

The use of a Medical Review Officer (MRO) is essential to protect the interests of your company and the donor. All non-negative presumptive positive results are reviewed by one of our Certified MRO's. Our MRO's are certified through American Association of Medical Review Officers (AAMRO) and/or the Medical Review Officer Certification Council (MROCC). The Medical Review Officer (MRO) helps protect both the rights of the employee being tested and the employer requiring the testing.

The MRO Performs Four Main Functions
  • Receive lab reports from the laboratory (as governed by regulations.)
  • Review lab reports for integrity, authenticity, false negatives, and false positives.
  • Interpret lab results, including verification of lab positives.
  • Report lab reports to employers (as defined by rules and regulations.)

  • Drug Test Collector News

    News and Info you can use as a Drug Test Collector of Urine Analysis UA's or DOT Federal Collections
    DATIA eNews
    DOT Releases 2018 Drug, Alcohol Random Testing Rates
    The Office of Drug and Alcohol Policy and Compliance (ODAPC) has updated the DOT annual random testing rates for 2018. These rates were last updated Thursday February 1st, 2018. These rates can be viewed at datia.org under the Resources section (please note you must be logged in to view the 'Members Only' Resources page) or can be viewed on ODAPC's website at https://www.transportation.gov/odapc/random-testing-rates
    Prop 203 Gives Medical Marijuana The Green Light
    Arizona Proposition 203, "a ballot measure asking the state's voters to legalize medical marijuana," just barely passed by less than .1% recently. This new law enables physicians to prescribe two and a half ounces of marijuana every two weeks to "patients with serious debilitating illnesses, including HIV/AIDS, glaucoma, Alzheimer's, Crohn's disease, cancer and multiple sclerosis. Patients who live more than 25 miles away from a licensed dispensary are allowed to grow up to 12 plants in their home as long as they have a permit and doctor's consent." Read the full story here.
    Question: Can you direct me to the procedures for a torn seal during a DOT Urine collection?


    Occasionally, the tamper-evident label/seal provided with the CCF will not properly adhere to the specimen bottle because of environmental conditions (e.g., moisture, temperature, specimen bottle material) or may be damaged or broken during the collection process. When this occurs, the collector should use the following corrective procedures:
    (a) If the seal is broken while being removed from the chain of custody form or during the application of the first seal on the primary bottle, the collector should transfer the information to a new CCF and use the seals from the second form.
    (b) If one seal is already in place on a bottle and the second seal is broken while being removed from the CCF or is broken during application on the second bottle or while the employee is initialing either seal, the collector should initiate a new CCF and provide an appropriate comment on the “Remarks” line in Step 5. The seals from the second CCF should be placed perpendicular to the original seals to avoid obscuring information on the original seals and must be initialed by the employee (both sets of employee initials should match). The collector should draw a line through the Specimen ID number and bar code (if present) on the original seals to ensure that the laboratory does not use that number for reporting the results. The collector should not pour the specimen into new bottles.
    (c) In both cases, the collector should ensure that all copies of the original (first) chain of custody form are destroyed or disposed of properly (e.g., shredded, torn into pieces). (
    DOT's Specimen Collection Guidelines)

    Drugtestingnews top links:

    • DOT Releases 2018 Drug Test Rates..
    • Nine Houston Residents Arrested in Biggest PCP Seizure in DEA History..
    • Medical Marijuana Raises Test Issues...
    View Drug Testing News. Click link bottom of this page for the current 49 CFR Part 40.
Sort By:
Page of 1
alere abbott DOT Nida 5 Panel Integrated Split Key Cup E-Z 5 Panel Integrated Split Key Cup
List Price $119.99
Product Price $114.95
Sale Price $112.25 Less Discounts
You save $7.74!
Lab locator service; d.o.t., drug, screen, drug screen, Nida 5 drugs, dot regulations, federal drug test, nationwide drug testing all points with quest or Labcorp specimen collection locations.